Microbot Medical Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $25.76 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Microbot Medical Inc had its IPO on 1992-03-25 under the ticker symbol MBOT.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Microbot Medical Inc has a staff strength of 18 employees.
Shares of Microbot Medical Inc opened at $2.2 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.11 - $2.2, and closed at $2.12.
This is a -3.64% slip from the previous day's closing price.
A total volume of 35,304 shares were traded at the close of the day’s session.
In the last one week, shares of Microbot Medical Inc have slipped by -3.2%.
Microbot Medical Inc's Key Ratios
Microbot Medical Inc has a market cap of $25.76 million, indicating a price to book ratio of 5.9469 and a price to sales ratio of 0.
In the last 12-months Microbot Medical Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-11676000. The EBITDA ratio measures Microbot Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Microbot Medical Inc’s operating margin was 0% while its return on assets stood at -68.75% with a return of equity of -128.9%.
In Q2, Microbot Medical Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Microbot Medical Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-1.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Microbot Medical Inc’s profitability.
Microbot Medical Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.9268. Its price to sales ratio in the trailing 12-months stood at 0.
Microbot Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $10.88 million
- Total Liabilities
- $1.32 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Microbot Medical Inc ended 2023 with $10.88 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.88 million while shareholder equity stood at $9.47 million.
Microbot Medical Inc ended 2023 with $0 in deferred long-term liabilities, $1.32 million in other current liabilities, 118000.00 in common stock, $-73901000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.72 million and cash and short-term investments were $9.92 million. The company’s total short-term debt was $225,000 while long-term debt stood at $0.
Microbot Medical Inc’s total current assets stands at $10.34 million while long-term investments were $0 and short-term investments were $4.20 million. Its net receivables were $0 compared to accounts payable of $240000.00 and inventory worth $0.
In 2023, Microbot Medical Inc's operating cash flow was $0 while its capital expenditure stood at $10000.
Comparatively, Microbot Medical Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Microbot Medical Inc stock is currently trading at $2.12 per share. It touched a 52-week high of $6.05 and a 52-week low of $6.05. Analysts tracking the stock have a 12-month average target price of $8.
Its 50-day moving average was $2.32 and 200-day moving average was $2.63 The short ratio stood at 1.11 indicating a short percent outstanding of 0%.
Around 206.7% of the company’s stock are held by insiders while 1939.6% are held by institutions.
Frequently Asked Questions About Microbot Medical Inc
Similar Industry Stocks (Medical Instruments & Supplies)
Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.